Suppr超能文献

克罗恩病的感染性发病机制。

Infectious etiopathogenesis of Crohn's disease.

作者信息

Carrière Jessica, Darfeuille-Michaud Arlette, Nguyen Hang Thi Thu

机构信息

Jessica Carrière, Arlette Darfeuille-Michaud, Hang Thi Thu Nguyen, Clermont Université, M2iSH, UMR 1071 Inserm/University of Auvergne, 63001 Clermont-Ferrand, France.

出版信息

World J Gastroenterol. 2014 Sep 14;20(34):12102-17. doi: 10.3748/wjg.v20.i34.12102.

Abstract

Important advances during the last decade have been made in understanding the complex etiopathogenesis of Crohn's disease (CD). While many gaps in our knowledge still exist, it has been suggested that the etiology of CD is multifactorial including genetic, environmental and infectious factors. The most widely accepted theory states that CD is caused by an aggressive immune response to infectious agents in genetically predisposed individuals. The rise of genome-wide association studies allowed the identification of loci and genetic variants in several components of host innate and adaptive immune responses to microorganisms in the gut, highlighting an implication of intestinal microbiota in CD etiology. Moreover, numerous independent studies reported a dysbiosis, i.e., a modification of intestinal microbiota composition, with an imbalance between the abundance of beneficial and harmful bacteria. Although microorganisms including viruses, yeasts, fungi and bacteria have been postulated as potential CD pathogens, based on epidemiological, clinicopathological, genetic and experimental evidence, their precise role in this disease is not clearly defined. This review summarizes the current knowledge of the infectious agents associated with an increased risk of developing CD. Therapeutic approaches to modulate the intestinal dysbiosis and to target the putative CD-associated pathogens, as well as their potential mechanisms of action are also discussed.

摘要

在过去十年中,我们对克罗恩病(CD)复杂的病因发病机制的理解取得了重要进展。尽管我们的知识仍存在许多空白,但有人提出,CD的病因是多因素的,包括遗传、环境和感染因素。最被广泛接受的理论认为,CD是由遗传易感个体对感染因子的强烈免疫反应引起的。全基因组关联研究的兴起使我们能够识别宿主对肠道微生物的固有免疫和适应性免疫反应的几个组成部分中的基因座和遗传变异,突出了肠道微生物群在CD病因中的作用。此外,许多独立研究报告了生态失调,即肠道微生物群组成的改变,有益菌和有害菌的丰度失衡。尽管包括病毒、酵母、真菌和细菌在内的微生物被认为是潜在的CD病原体,但基于流行病学、临床病理学、遗传学和实验证据,它们在这种疾病中的精确作用尚未明确界定。这篇综述总结了目前与患CD风险增加相关的感染因子的知识。还讨论了调节肠道生态失调和针对假定的CD相关病原体的治疗方法及其潜在作用机制。

相似文献

1
Infectious etiopathogenesis of Crohn's disease.
World J Gastroenterol. 2014 Sep 14;20(34):12102-17. doi: 10.3748/wjg.v20.i34.12102.
2
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014.
3
Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?
World J Gastroenterol. 2014 Feb 7;20(5):1192-210. doi: 10.3748/wjg.v20.i5.1192.
4
Evidence for the involvement of infectious agents in the pathogenesis of Crohn's disease.
World J Gastroenterol. 2008 Feb 14;14(6):845-52. doi: 10.3748/wjg.14.845.
6
Role of antibiotics for treatment of inflammatory bowel disease.
World J Gastroenterol. 2016 Jan 21;22(3):1078-87. doi: 10.3748/wjg.v22.i3.1078.
8
The Microbiome in Crohn's Disease: Role in Pathogenesis and Role of Microbiome Replacement Therapies.
Gastroenterol Clin North Am. 2017 Sep;46(3):481-492. doi: 10.1016/j.gtc.2017.05.004. Epub 2017 Jul 19.
9
Dysbiotic gut microbiome: A key element of Crohn's disease.
Comp Immunol Microbiol Infect Dis. 2015 Dec;43:36-49. doi: 10.1016/j.cimid.2015.10.005. Epub 2015 Oct 25.
10
Is treating the gut microbiome the key to achieving better outcomes in cirrhosis?
Expert Rev Gastroenterol Hepatol. 2019 Jan;13(1):1-2. doi: 10.1080/17474124.2019.1543587. Epub 2018 Nov 13.

引用本文的文献

1
Autophagy and Bacterial infections.
Autophagy Rep. 2025 Sep 1;4(1):2542904. doi: 10.1080/27694127.2025.2542904. eCollection 2025.
2
Unmet health-related needs in patients with Crohn's disease in Belgium: a mixed-methods study.
Arch Public Health. 2025 Jun 13;83(1):151. doi: 10.1186/s13690-025-01632-1.
4
Challenges of concurrent HIV infection in the course and management of Crohn's disease.
J Med Life. 2025 Mar;18(3):171-178. doi: 10.25122/jml-2024-0359.
5
Gut Microbiota Modulation in IBD: From the Old Paradigm to Revolutionary Tools.
Int J Mol Sci. 2025 Mar 27;26(7):3059. doi: 10.3390/ijms26073059.
6
Mapping Crohn's Disease Pathogenesis with Mycobacterium paratuberculosis: A Hijacking by a Stealth Pathogen.
Dig Dis Sci. 2024 Jul;69(7):2289-2303. doi: 10.1007/s10620-024-08508-4. Epub 2024 Jun 19.
8
Amyloid, Crohn's disease, and Alzheimer's disease - are they linked?
Front Cell Infect Microbiol. 2024 May 8;14:1393809. doi: 10.3389/fcimb.2024.1393809. eCollection 2024.

本文引用的文献

1
Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect.
J Crohns Colitis. 2014 Aug;8(8):717-25. doi: 10.1016/j.crohns.2014.02.002. Epub 2014 Mar 11.
2
Crohn's disease: a review of treatment options and current research.
Cell Immunol. 2013 Nov-Dec;286(1-2):45-52. doi: 10.1016/j.cellimm.2013.11.003. Epub 2013 Nov 20.
3
Fecal microbiota transplantation for severe enterocolonic fistulizing Crohn's disease.
World J Gastroenterol. 2013 Nov 7;19(41):7213-6. doi: 10.3748/wjg.v19.i41.7213.
4
5
Fecal transplantation for the treatment of recurrent clostridium difficile infection.
N Am J Med Sci. 2013 Jun;5(6):339-43. doi: 10.4103/1947-2714.114163.
6
Defensins: natural component of human innate immunity.
Hum Immunol. 2013 Sep;74(9):1069-79. doi: 10.1016/j.humimm.2013.05.008. Epub 2013 Jun 10.
7
Environment and the inflammatory bowel diseases.
Can J Gastroenterol. 2013 Mar;27(3):e18-24. doi: 10.1155/2013/102859.
8
Saccharomyces boulardii does not prevent relapse of Crohn's disease.
Clin Gastroenterol Hepatol. 2013 Aug;11(8):982-7. doi: 10.1016/j.cgh.2013.02.021. Epub 2013 Mar 1.
10
Autophagy and Crohn's disease.
J Innate Immun. 2013;5(5):434-43. doi: 10.1159/000345129. Epub 2013 Jan 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验